BCL2L1 and breast carcinoma: By applying this unique design principle to repress the anti-apoptotic B-cell lymphoma-extra-large (BCL-xL) gene, we successfully induced apoptosis in target breast cancer cells in a miRNA-dependent manner, both in vitro and in vivo.